Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Another GREAT Quarter From Adobe Systems Incorporated Stock! (ADBE)

By John Divine, InvestorPlace Assistant Editor
Adobe (ADBE) stock is gaining ground after a stellar quarter characterized by strong growth in the cloud. Still, shares remain attractive.

YHOO Stock Is a Buy Regardless of What’s Divested

By Brian Nichols, InvestorPlace Contributor
With a slew of options and loads of unlocked value, YHOO is a must-buy. Here's a look at the different options it has.

How Management Can Push IBM Stock Much Higher in 2016

By Brian Nichols, InvestorPlace Contributor
IBM stock could soar in 2016, but management must do this one thing if it wants to restore investors' faith.

5 Stocks You MUST Watch in 2016

By Rick Rouse, Editor, Momentum Options
Here’s a peek at five stocks to watch as we head into 2016 -- four bullish and one bearish -- because I believe they’ll play out favorably regardless of what the Fed decides.

Chipotle Mexican Grill, Inc.: Why CMG Stock Is a Brewing Value

By Hilary Kramer, Editor, GameChangers
Chipotle stock may look screwed, but CMG is a value in the making. Go long CMG shares now.

TWTR Is Showing Ads to Logged-Off Users; Time to Buy Twitter Stock

By Brian Nichols, InvestorPlace Contributor
Twitter stock will surge as advertisements to logged-out users ramp up and the revenues start to climb.

Equifax Is Your Stability In a Sea Of Volatility: EFX Stock

By Louis Navellier, Editor, Growth Investor
Equifax is a solid company, and EFX stock is in a unique position to thrive regardless of market performance or the economy in general.

Biotech Stocks That Could Double in 2016: Celldex Therapeutics (CLDX)

By Brian Nichols, InvestorPlace Contributor
Celldex Therapeutics (CLDX) is primed for a boffo 2016 as Rintega's FDA approval, CDX-011's data and a cheap stock will cause CLDX stock to double.

Qualcomm: China Woes Make QCOM a Bargain

By Richard Band
This leading mobile chipmaker has always known how to pivot, so recent lawsuit won't keep QCOM down.

Microsoft Stock (MSFT): It’s Going To Be A Good 2016

By Tom Taulli, InvestorPlace Contributor
The cloud is definitely a megatrend and Microsoft stock should benefit nicely. So going into next year, the prospects certainly look bright.

Target Stock Is an Investment in an Experience (TGT)

By James Brumley, InvestorPlace Feature Writer
It doesn't add tangible value to Target stock, but goodwill and thrilled customers help the top and bottom lines in a big way. Just ask Disney.

Dow Chemical and DuPont Deal Is a No-Brainer (DD, DOW)

By Dan Burrows, InvestorPlace Feature Writer
Dow Chemical and DuPont are right to merge and then break up into focused companies to better succeed amid sluggish global growth.

Chipotle: CMG Stock Pummeled as Food Illness Outbreaks Rage

By Josh Enomoto, InvestorPlace Contributor
Strong fundamentals haven't stopped CMG stock from hemorrhaging, but some hope remains for the embattled company.

Why Fitbit Stock Should Be At the Top of Your Christmas Wish List (FIT)

By Brian Nichols, InvestorPlace Contributor
Even with conservative estimates, Fitbit stock is poised for much larger long-term gains.

Traffic Outlook Sends Southwest Into a Tailspin (LUV)

By James Brumley, InvestorPlace Feature Writer
The bulls may have overshot Southwest Airlines (LUV), but that's being corrected now. Time to put LUV stock on your watchlist.

3 Glittery Gold Miners to Buy Today

By Aaron Levitt, InvestorPlace Contributor
Investors have been hating on gold stocks for a long time, but now they're looking like a huge contrarian buy. Here are 3 to add today.

5 Stocks to Buy for December

By Dan Burrows, InvestorPlace Feature Writer
Looking for a few stocks to buy to ride December's usual upswing? Try these winners that boast strong seasonality and promising charts.

Netflix, Inc. Won’t Languish Long If the Bulls Have Their Way (NFLX)

By Dan Burrows, InvestorPlace Feature Writer
The market may worry about cost concerns and troubles going global, but investor sentiment in Netflix (NFLX) is too strong to be broken.

Toll Brothers Takes a Hit, But Don’t Count It Out Yet (TOL)

By Dan Burrows, InvestorPlace Feature Writer
An earnings miss and impending rate hike could hold down Toll Brothers Inc (TOL) in the nearer term, but fundamentals remain strong.
Load More Articles